Preoperative ESR1 mRNA therapy in cases with an advanced stage of ER-negative or TNBC-type breast cancer may result in an obvious tumor response coupled with stimulated immune-competent cells in the neighboring tissues. This evidence concerns the gene ESR1 and neoplasm.